AR084864A1 - Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso - Google Patents
Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho procesoInfo
- Publication number
- AR084864A1 AR084864A1 ARP120100138A ARP120100138A AR084864A1 AR 084864 A1 AR084864 A1 AR 084864A1 AR P120100138 A ARP120100138 A AR P120100138A AR P120100138 A ARP120100138 A AR P120100138A AR 084864 A1 AR084864 A1 AR 084864A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- optionally substituted
- compound
- preparation
- girasa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Reivindicación 1: Un método para la preparación de un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo, en donde R es H o F; y cada uno de R3, R4, y R5 es independientemente un alquilo opcionalmente sustituido, o un grupo hidroxilo opcionalmente protegido: que comprende la provisión de un compuesto de fenilpirimidina de fórmula (2) en donde R es H o F, y cada uno de R3, R4 y R5 es independientemente un alquilo opcionalmente sustituido o un grupo hidroxilo opcionalmente protegido; y la reacción del compuesto de fenilpirimidina de fórmula (2) con un derivado de urea de fórmula (3) ó (4), en donde R6 es un alquilo opcionalmente sustituido, un arilo opcionalmente sustituido, un carbociclo no saturado o saturado opcionalmente sustituido, o un heterociclo no saturado o saturado opcionalmente sustituido para proporcionar un compuesto de fórmula (1); y hacer reaccionar parcialmente el compuesto de formula (1) con un ácido adecuado para proporcionar una sal farmacéuticamente aceptable del compuesto de fórmula (1).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161432990P | 2011-01-14 | 2011-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR084864A1 true AR084864A1 (es) | 2013-07-10 |
Family
ID=45815947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120100138A AR084864A1 (es) | 2011-01-14 | 2012-01-16 | Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8471014B2 (es) |
| EP (1) | EP2663556B1 (es) |
| JP (1) | JP6006235B2 (es) |
| KR (1) | KR101882172B1 (es) |
| CN (1) | CN103384665B (es) |
| AR (1) | AR084864A1 (es) |
| AU (1) | AU2012205420B2 (es) |
| BR (1) | BR112013017968B1 (es) |
| CA (1) | CA2824519C (es) |
| ES (1) | ES2526902T3 (es) |
| IL (1) | IL227405B (es) |
| MX (1) | MX355561B (es) |
| NZ (1) | NZ612920A (es) |
| PT (1) | PT2663556E (es) |
| RU (1) | RU2619116C2 (es) |
| SG (1) | SG191945A1 (es) |
| TW (1) | TWI534143B (es) |
| WO (1) | WO2012097274A1 (es) |
| ZA (1) | ZA201305232B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX339455B (es) * | 2011-01-14 | 2016-05-27 | Vertex Pharma | Inhibidores de pirimidina y topoisomerasa iv. |
| CN103403000B (zh) * | 2011-01-14 | 2017-05-31 | 斯派罗吹耐姆公司 | 固体形式的促旋酶抑制剂（r）‑1‑乙基‑3‑[6‑氟‑5‑[2‑（1‑羟基‑1‑甲基‑乙基）嘧啶‑5‑基]‑7‑（四氢呋喃‑2‑基）‑1氢‑苯并咪唑‑2‑基]脲 |
| RU2619116C2 (ru) | 2011-01-14 | 2017-05-12 | Сперо Тринем, Инк. | Способ получения ингибиторов гиразы и топоизомеразы iv |
| MX351555B (es) * | 2011-01-14 | 2017-10-19 | Spero Trinem Inc | Formas solidas de inhibidor de girasa (r)-1-etil-3-[5-[2-(1-hidrox i-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzim idazol-2-il]urea. |
| US9125922B2 (en) * | 2011-06-20 | 2015-09-08 | Vertex Pharmaceuticals Incorporated | Phosphate esters of gyrase and topoisomerase inhibitors |
| AR093226A1 (es) * | 2012-07-18 | 2015-05-27 | Vertex Pharma | Formas solidas de dihidrogeno fosfato de (r)-2-(5-(2-(3-etilureido)-6-fluoro-7-(tetrahidrofuran-2-il)-1h-benzo[d]imidazol-5-il)pirimidin-2-il)propan-2-ilo y sus sales |
| US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
| KR20160115986A (ko) | 2014-02-03 | 2016-10-06 | 스페로 자이레이스, 인크 | 폴리믹신을 포함하는 항균성 조합 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2015676A1 (de) | 1970-04-02 | 1971-10-21 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Neue Imine der 2-Formyl-chinoxalindi-N-oxidcarbon-säure-(3) und deren Salze, Verfahren zu ihrer Herstellung und ihre Verwendung als antimikrobielle Mittel |
| US4174400A (en) | 1978-09-13 | 1979-11-13 | Merck & Co., Inc. | Anthelmintic benzimidazoles |
| US4512998A (en) | 1980-10-20 | 1985-04-23 | Schering Corporation | Anthelmintic benzimidazole carbamates |
| CA2028530A1 (en) | 1989-11-21 | 1991-05-22 | Christian Hubschwerlen | Substituted pyrimidobenzimidazole derivatives |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| HRP960159A2 (en) | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
| US5643935A (en) | 1995-06-07 | 1997-07-01 | The University Of North Carolina At Chapel Hill | Method of combatting infectious diseases using dicationic bis-benzimidazoles |
| TW538046B (en) | 1998-01-08 | 2003-06-21 | Hoechst Marion Roussel Inc | Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof |
| AUPP873799A0 (en) | 1999-02-17 | 1999-03-11 | Fujisawa Pharmaceutical Co., Ltd. | Pyridine compounds |
| GB9911594D0 (en) | 1999-05-19 | 1999-07-21 | Smithkline Beecham Plc | Novel compounds |
| GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| EP1341769B1 (en) | 2000-12-15 | 2007-10-17 | Vertex Pharmaceuticals Incorporated | Bacterial gyrase inhibitors and uses thereof |
| AU2003245442B2 (en) * | 2002-06-13 | 2009-02-05 | Vertex Pharmaceuticals Incorporated | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections |
| US7582641B2 (en) | 2003-01-31 | 2009-09-01 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US8193352B2 (en) | 2003-01-31 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US7618974B2 (en) | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US8404852B2 (en) | 2003-01-31 | 2013-03-26 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
| US7569591B2 (en) | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| BRPI0407519A (pt) * | 2003-03-07 | 2006-02-14 | Kowa Co | derivados de benzofurano |
| AU2006311729A1 (en) * | 2005-11-07 | 2007-05-18 | Vertex Pharmaceuticals Incorporated | Benzimidazole derivatives as gyrase inhibitors |
| GB0724349D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Antibacterial agents |
| GB0612428D0 (en) | 2006-06-22 | 2006-08-02 | Prolysis Ltd | Antibacterial agents |
| US8481544B2 (en) | 2006-06-22 | 2013-07-09 | Biota Europe Limited | Antibacterial compositions |
| UA96964C2 (ru) | 2006-12-04 | 2011-12-26 | Астразенека Аб | Соединения полициклической мочевины с антибактериальными свойствами |
| GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
| EP2321309A1 (en) | 2008-06-25 | 2011-05-18 | Ranbaxy Laboratories Limited | Benzothiazoles and aza-analogues thereof use as antibacterial agents |
| EP2475666A2 (en) | 2009-09-11 | 2012-07-18 | Trius Therapeutics, Inc. | Gyrase inhibitors |
| EA023350B1 (ru) | 2009-10-16 | 2016-05-31 | Мелинта Терапьютикс, Инк. | Противомикробные соединения, способы их получения и применение |
| US9181234B2 (en) | 2010-10-08 | 2015-11-10 | Biota Europe Ltd. | Antibacterial compounds |
| RU2619116C2 (ru) | 2011-01-14 | 2017-05-12 | Сперо Тринем, Инк. | Способ получения ингибиторов гиразы и топоизомеразы iv |
| MX339455B (es) * | 2011-01-14 | 2016-05-27 | Vertex Pharma | Inhibidores de pirimidina y topoisomerasa iv. |
| CN103403000B (zh) | 2011-01-14 | 2017-05-31 | 斯派罗吹耐姆公司 | 固体形式的促旋酶抑制剂（r）‑1‑乙基‑3‑[6‑氟‑5‑[2‑（1‑羟基‑1‑甲基‑乙基）嘧啶‑5‑基]‑7‑（四氢呋喃‑2‑基）‑1氢‑苯并咪唑‑2‑基]脲 |
| MX351555B (es) * | 2011-01-14 | 2017-10-19 | Spero Trinem Inc | Formas solidas de inhibidor de girasa (r)-1-etil-3-[5-[2-(1-hidrox i-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzim idazol-2-il]urea. |
| US9125922B2 (en) * | 2011-06-20 | 2015-09-08 | Vertex Pharmaceuticals Incorporated | Phosphate esters of gyrase and topoisomerase inhibitors |
| US8906902B2 (en) | 2012-03-22 | 2014-12-09 | Biota Europe Limited | Antibacterial compounds |
| AR093226A1 (es) * | 2012-07-18 | 2015-05-27 | Vertex Pharma | Formas solidas de dihidrogeno fosfato de (r)-2-(5-(2-(3-etilureido)-6-fluoro-7-(tetrahidrofuran-2-il)-1h-benzo[d]imidazol-5-il)pirimidin-2-il)propan-2-ilo y sus sales |
| US9572809B2 (en) * | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
-
2012
- 2012-01-13 RU RU2013137751A patent/RU2619116C2/ru active
- 2012-01-13 PT PT127084168T patent/PT2663556E/pt unknown
- 2012-01-13 AU AU2012205420A patent/AU2012205420B2/en not_active Ceased
- 2012-01-13 WO PCT/US2012/021281 patent/WO2012097274A1/en not_active Ceased
- 2012-01-13 CN CN201280009909.2A patent/CN103384665B/zh not_active Expired - Fee Related
- 2012-01-13 CA CA2824519A patent/CA2824519C/en active Active
- 2012-01-13 KR KR1020137018399A patent/KR101882172B1/ko active Active
- 2012-01-13 SG SG2013053418A patent/SG191945A1/en unknown
- 2012-01-13 TW TW101101505A patent/TWI534143B/zh active
- 2012-01-13 NZ NZ612920A patent/NZ612920A/en not_active IP Right Cessation
- 2012-01-13 ES ES12708416.8T patent/ES2526902T3/es active Active
- 2012-01-13 US US13/349,884 patent/US8471014B2/en active Active
- 2012-01-13 MX MX2013008164A patent/MX355561B/es active IP Right Grant
- 2012-01-13 BR BR112013017968-6A patent/BR112013017968B1/pt not_active IP Right Cessation
- 2012-01-13 EP EP12708416.8A patent/EP2663556B1/en active Active
- 2012-01-13 JP JP2013549579A patent/JP6006235B2/ja active Active
- 2012-01-16 AR ARP120100138A patent/AR084864A1/es active IP Right Grant
-
2013
- 2013-05-28 US US13/903,506 patent/US8912326B2/en active Active
- 2013-07-10 IL IL227405A patent/IL227405B/en active IP Right Grant
- 2013-07-11 ZA ZA2013/05232A patent/ZA201305232B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2526902T3 (es) | 2015-01-16 |
| EP2663556B1 (en) | 2014-10-15 |
| SG191945A1 (en) | 2013-08-30 |
| AU2012205420B2 (en) | 2016-12-08 |
| KR20140037028A (ko) | 2014-03-26 |
| ZA201305232B (en) | 2014-11-26 |
| US8471014B2 (en) | 2013-06-25 |
| CN103384665B (zh) | 2018-01-09 |
| BR112013017968B1 (pt) | 2021-03-16 |
| AU2012205420A1 (en) | 2013-08-01 |
| CN103384665A (zh) | 2013-11-06 |
| TWI534143B (zh) | 2016-05-21 |
| KR101882172B1 (ko) | 2018-07-26 |
| US20130261305A1 (en) | 2013-10-03 |
| JP2014503558A (ja) | 2014-02-13 |
| CA2824519A1 (en) | 2012-07-19 |
| BR112013017968A2 (pt) | 2016-07-12 |
| RU2619116C2 (ru) | 2017-05-12 |
| EP2663556A1 (en) | 2013-11-20 |
| US8912326B2 (en) | 2014-12-16 |
| TW201307332A (zh) | 2013-02-16 |
| IL227405B (en) | 2018-05-31 |
| IL227405A0 (en) | 2013-09-30 |
| JP6006235B2 (ja) | 2016-10-12 |
| NZ612920A (en) | 2015-10-30 |
| RU2013137751A (ru) | 2015-02-20 |
| MX355561B (es) | 2018-04-23 |
| PT2663556E (pt) | 2014-11-27 |
| MX2013008164A (es) | 2013-08-27 |
| CA2824519C (en) | 2020-06-16 |
| WO2012097274A1 (en) | 2012-07-19 |
| US20120184742A1 (en) | 2012-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR084864A1 (es) | Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso | |
| AR116907A2 (es) | Derivado de diazabiciclooctano ópticamente activo y proceso para su preparación | |
| MX377552B (es) | Proceso para preparar un compuesto antiviral de formula i. | |
| CA2875877C (en) | Syk inhibitors | |
| AR094314A1 (es) | Inhibidores de fosfatidilinositol 3-cinasa | |
| TN2011000400A1 (en) | Inhibitors of beta-secretase | |
| JO3387B1 (ar) | مشتقات بيتولين | |
| AR085155A1 (es) | Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos | |
| IN2014MN02106A (es) | ||
| BR112013020996A2 (pt) | derivados aminobutíricos substituídos como inibidores de neprilisina | |
| MD20180040A2 (ro) | Inhibitori ai virusului hepatic C | |
| AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
| PH12017500048A1 (en) | Pyridone derivative having tetrahydropyranylmethyl group | |
| IN2014MN01521A (es) | ||
| BR112013011593A2 (pt) | cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo | |
| AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
| PH12015500008B1 (en) | Dimethyl-benzoic acid compounds | |
| CO6231027A2 (es) | Metodos e intermediarios para preparar compuestos de lactama lactoma de 8 atomos de carbono activos como inhibidores de renina | |
| SA523451905B1 (ar) | Cdk2 مركبات بيريميدينيل-بيرازول بها استبدال كمثبطات | |
| IN2014DN00144A (es) | ||
| PE20142244A1 (es) | Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina | |
| IN2014CN04449A (es) | ||
| AR075915A1 (es) | Proceso para la obtencion de derivados de acido propionico | |
| AR082881A1 (es) | Proceso para preparar un derivado de piperidina, intermediario para sintetizar un medicamento | |
| TN2012000620A1 (fr) | Procede de preparation du sel de l-arginine du perindopril |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |